ECMM/ISHAM recommendations for clinical management of COVID‐19 associated mucormycosis in low‐ and middle‐income countries
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
ECMM/ISHAM recommendations for clinical management of COVID‐19 associated mucormycosis in low‐ and middle‐income countries
Authors
Keywords
-
Journal
MYCOSES
Volume 64, Issue 9, Pages 1028-1037
Publisher
Wiley
Online
2021-06-17
DOI
10.1111/myc.13335
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Epidemiology of Mucormycosis in India
- (2021) Hariprasath Prakash et al. Microorganisms
- When Uncontrolled Diabetes Mellitus and Severe COVID-19 Converge: The Perfect Storm for Mucormycosis
- (2021) Teny M. John et al. Journal of Fungi
- Conventional PCR as a reliable method for diagnosing invasive mucormycosis in resource-limited settings
- (2021) Mragnayani Pandey et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India
- (2021) Awadhesh Kumar Singh et al. Diabetes & Metabolic Syndrome-Clinical Research & Reviews
- Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan
- (2020) Xiaochen Li et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Evaluation of MucorGenius® mucorales PCR assay for the diagnosis of pulmonary mucormycosis
- (2020) Hélène Guegan et al. JOURNAL OF INFECTION
- Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19
- (2020) Maximilian Ackermann et al. NEW ENGLAND JOURNAL OF MEDICINE
- COVID-19 as part of the hyperferritinemic syndromes: the role of iron depletion therapy
- (2020) Carlo Perricone et al. IMMUNOLOGIC RESEARCH
- Iron: Innocent bystander or vicious culprit in COVID-19 pathogenesis?
- (2020) Marvin Edeas et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- COVID-19 associated invasive candidiasis
- (2020) Abdullah M.S. Al-Hatmi et al. JOURNAL OF INFECTION
- Hyperferritinemia in critically ill COVID-19 patients – Is ferritin the product of inflammation or a pathogenic mediator?
- (2020) Jenifer Gómez-Pastora et al. CLINICA CHIMICA ACTA
- Hyperglycemia and COVID-19: What was known and what is really new?
- (2020) Antonio Ceriello DIABETES RESEARCH AND CLINICAL PRACTICE
- COVID-19 endocrinopathy with hindsight from SARS
- (2020) Narasimhan Kothandaraman et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Molecular identification of pathogenic fungi in formalin-fixed and paraffin-embedded tissues
- (2020) Joseph Jillwin et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance
- (2020) Philipp Koehler et al. LANCET INFECTIOUS DISEASES
- High GRP78 levels in Covid-19 infection: A case-control study
- (2020) Ramazan Sabirli et al. LIFE SCIENCES
- An aero mycological analysis of Mucormycetes in indoor and outdoor environments of northern India
- (2019) Hariprasath Prakash et al. MEDICAL MYCOLOGY
- A multicentre observational study on the epidemiology, risk factors, management and outcomes of mucormycosis in India
- (2019) A. Patel et al. CLINICAL MICROBIOLOGY AND INFECTION
- Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium
- (2019) Oliver A Cornely et al. LANCET INFECTIOUS DISEASES
- Challenges in the diagnosis and treatment of mucormycosis
- (2018) A Skiada et al. MEDICAL MYCOLOGY
- Molecular diagnosis of rhino-orbito-cerebral mucormycosis from fresh tissue samples
- (2017) Kamran Zaman et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Increasing incidence of mucormycosis in a large Spanish hospital from 2007 to 2015: Epidemiology and microbiological characterization of the isolates
- (2017) Jesús Guinea et al. PLoS One
- The environmental source of emergingApophysomyces variabilisinfection in India
- (2016) Hariprasath Prakash et al. MEDICAL MYCOLOGY
- Infection Risk and Safety of Corticosteroid Use
- (2016) Jameel Youssef et al. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
- Multicenter Evaluation of MIC Distributions for Epidemiologic Cutoff Value Definition To Detect Amphotericin B, Posaconazole, and Itraconazole Resistance among the Most Clinically Relevant Species of Mucorales
- (2015) A. Espinel-Ingroff et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- CotH3 mediates fungal invasion of host cells during mucormycosis
- (2013) Teclegiorgis Gebremariam et al. JOURNAL OF CLINICAL INVESTIGATION
- Healthcare-Associated Mucormycosis
- (2012) Blandine Rammaert et al. CLINICAL INFECTIOUS DISEASES
- A Global Analysis of Mucormycosis in France: The RetroZygo Study (2005-2007)
- (2012) F. Lanternier et al. CLINICAL INFECTIOUS DISEASES
- Pathogenesis of Mucormycosis
- (2012) Ashraf S. Ibrahim et al. CLINICAL INFECTIOUS DISEASES
- The endothelial cell receptor GRP78 is required for mucormycosis pathogenesis in diabetic mice
- (2010) Mingfu Liu et al. JOURNAL OF CLINICAL INVESTIGATION
- Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes
- (2009) Jin-Kui Yang et al. ACTA DIABETOLOGICA
- The ecology of the Zygomycetes and its impact on environmental exposure
- (2009) M. Richardson CLINICAL MICROBIOLOGY AND INFECTION
- Rhinocerebral mucormycosis in an adolescent with type 1 diabetes mellitus: case report
- (2008) R. Ganesh et al. ANNALS OF TROPICAL PAEDIATRICS
- Delaying Amphotericin B–Based Frontline Therapy Significantly Increases Mortality among Patients with Hematologic Malignancy Who Have Zygomycosis
- (2008) Georgios Chamilos et al. CLINICAL INFECTIOUS DISEASES
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started